Tomáš Vacı́k

827 total citations
27 papers, 628 citations indexed

About

Tomáš Vacı́k is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tomáš Vacı́k has authored 27 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Genetics and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tomáš Vacı́k's work include Epigenetics and DNA Methylation (7 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and RNA modifications and cancer (4 papers). Tomáš Vacı́k is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and RNA modifications and cancer (4 papers). Tomáš Vacı́k collaborates with scholars based in Czechia, Slovakia and United States. Tomáš Vacı́k's co-authors include Ondřej Machoň, Zbyněk Kozmík, Stefan Krauß, Jiřı́ Forejt, Olga Machoňová, Mattias Backman, Greg Lemke, Ivan Raška, Jennifer L. Stubbs and Naoko Fujimura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Tomáš Vacı́k

26 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomáš Vacı́k Czechia 11 497 183 100 92 40 27 628
Angelo Iulianella Canada 17 557 1.1× 281 1.5× 106 1.1× 70 0.8× 45 1.1× 29 754
Oz Pomp United States 15 441 0.9× 106 0.6× 82 0.8× 97 1.1× 74 1.9× 18 638
Ruth Simon United States 12 694 1.4× 200 1.1× 79 0.8× 112 1.2× 48 1.2× 16 853
Ralitsa Petrova United States 8 517 1.0× 128 0.7× 133 1.3× 87 0.9× 37 0.9× 11 678
Stine Büchmann-Møller United States 8 436 0.9× 110 0.6× 62 0.6× 70 0.8× 38 0.9× 9 559
Kristine A. Henningfeld Germany 14 572 1.2× 107 0.6× 56 0.6× 100 1.1× 21 0.5× 23 690
Dirk‐Jan Kleinjan United Kingdom 7 437 0.9× 147 0.8× 103 1.0× 38 0.4× 15 0.4× 9 541
Christoph Wiegreffe Germany 10 358 0.7× 101 0.6× 69 0.7× 80 0.9× 16 0.4× 17 493
Amélie Wegener France 7 458 0.9× 75 0.4× 194 1.9× 69 0.8× 57 1.4× 12 621
Susan Reijntjes United Kingdom 10 411 0.8× 118 0.6× 52 0.5× 114 1.2× 25 0.6× 12 521

Countries citing papers authored by Tomáš Vacı́k

Since Specialization
Citations

This map shows the geographic impact of Tomáš Vacı́k's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Vacı́k with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Vacı́k more than expected).

Fields of papers citing papers by Tomáš Vacı́k

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Vacı́k. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Vacı́k. The network helps show where Tomáš Vacı́k may publish in the future.

Co-authorship network of co-authors of Tomáš Vacı́k

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Vacı́k. A scholar is included among the top collaborators of Tomáš Vacı́k based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Vacı́k. Tomáš Vacı́k is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Canová, Nikolina Kutinová, et al.. (2025). Effectiveness and safety of the SREBP1/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression. European Journal of Pharmacology. 1003. 177890–177890. 1 indexed citations
3.
Liška, František, et al.. (2023). Lysine Demethylase KDM2A Promotes Proteasomal Degradation of TCF/LEF Transcription Factors in a Neddylation-Dependent Manner. Cells. 12(22). 2620–2620. 3 indexed citations
4.
Vacı́k, Tomáš, et al.. (2023). Non-canonical DNA structures in the human ribosomal DNA. Histochemistry and Cell Biology. 160(6). 499–515. 7 indexed citations
5.
Kučera, Tomáš, et al.. (2023). Pharmacological effects of mTORC1/C2 inhibitor in a preclinical model of NASH progression. Biomedicine & Pharmacotherapy. 167. 115447–115447. 6 indexed citations
6.
Vacı́k, Tomáš, et al.. (2022). Secretory carrier-associated membrane protein 2 (SCAMP2) regulates cell surface expression of T-type calcium channels. Molecular Brain. 15(1). 1–1. 6 indexed citations
7.
Michaličková, Danica, Tomáš Kučera, Tomáš Vacı́k, et al.. (2022). Detection of galanin receptors in the spinal cord in experimental autoimmune encephalomyelitis. Biomedical Papers. 167(1). 36–42. 2 indexed citations
8.
Souza, Ivana A., Tomáš Vacı́k, Jozef Hertecant, et al.. (2021). De novo SCN8A and inherited rare CACNA1H variants associated with severe developmental and epileptic encephalopathy. Molecular Brain. 14(1). 126–126. 8 indexed citations
9.
Liška, František, et al.. (2020). Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling. PLoS ONE. 15(10). e0236612–e0236612. 10 indexed citations
10.
Vacı́k, Tomáš, et al.. (2019). Life time of some RNA products of rDNA intergenic spacer in HeLa cells. Histochemistry and Cell Biology. 152(4). 271–280. 5 indexed citations
11.
Vacı́k, Tomáš & Ivan Raška. (2017). Alternative intronic promoters in development and disease. PROTOPLASMA. 254(3). 1201–1206. 13 indexed citations
12.
Kalasová, Ilona, et al.. (2017). PIP2 epigenetically represses rRNA genes transcription interacting with PHF8. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1863(3). 266–275. 27 indexed citations
13.
Slavotinek, Anne, Ryan Chao, Tomáš Vacı́k, et al.. (2011). VAX1mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: The first description of aVAX1phenotype in humans. Human Mutation. 33(2). 364–368. 56 indexed citations
14.
Vacı́k, Tomáš, Jennifer L. Stubbs, & Greg Lemke. (2011). A novel mechanism for the transcriptional regulation of Wnt signaling in development. Genes & Development. 25(17). 1783–1795. 55 indexed citations
15.
16.
Machoň, Ondřej, Mattias Backman, Olga Machoňová, et al.. (2007). A dynamic gradient of Wnt signaling controls initiation of neurogenesis in the mammalian cortex and cellular specification in the hippocampus. Developmental Biology. 311(1). 223–237. 167 indexed citations
17.
Fujimura, Naoko, Tomáš Vacı́k, Ondřej Machoň, et al.. (2006). Wnt-mediated Down-regulation of Sp1 Target Genes by a Transcriptional Repressor Sp5. Journal of Biological Chemistry. 282(2). 1225–1237. 66 indexed citations
18.
Vacı́k, Tomáš & Jiřı́ Forejt. (2003). Quantification of expression and methylation of the Igf2r imprinted gene in segmental trisomic mouse model. Genomics. 82(3). 261–268. 41 indexed citations
19.
Forejt, Jiřı́, Tomáš Vacı́k, & Soňa Gregorová. (2003). Segmental trisomy of mouse chromosome 17: introducing an alternative model of Down's syndrome. Comparative and Functional Genomics. 4(6). 647–652. 1 indexed citations
20.
Štěpánek, Václav, et al.. (1999). Indigenous plasmids in a production line of strains for penicillin G acylase derived fromEscherichia coli W. Folia Microbiologica. 44(3). 263–266. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelo Iulianella Breakdown of academic impact, for papers by Oz Pomp Breakdown of academic impact, for papers by Ruth Simon Breakdown of academic impact, for papers by Ralitsa Petrova Breakdown of academic impact, for papers by Stine Büchmann-Møller Breakdown of academic impact, for papers by Kristine A. Henningfeld Breakdown of academic impact, for papers by Dirk‐Jan Kleinjan Breakdown of academic impact, for papers by Christoph Wiegreffe Breakdown of academic impact, for papers by Amélie Wegener Breakdown of academic impact, for papers by Susan Reijntjes
Rankless by CCL
2026